Relmada Therapeutics Announces Poster Presentations at the 2021 Society of Biological Psychiatry Annual Meeting
/PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today...
Tim Mccarthy Relmada Therapeutics Inc Society Of Biological Psychiatry Securities Exchange Relmada Therapeutics Biological Psychiatry
Source: prnewswire.com